com_avail_chiral.cdx

Size: px
Start display at page:

Download "com_avail_chiral.cdx"

Transcription

1 Commercially Available Chiral Synthetic Units > Amino Acids C L-Alanine (Ala, A) [ ] / 100g * D-Ala: [ ] / 100g * araninamide-cl: [ ] / 5g * t Bu ester-cl [ ] / 5g * Et ester-cl [ ] / 25g * Me ester-cl [ ] / 25g * D-Ala-Me-ester-Cl [ ] / 25g * -Boc-D-Ala: [ ] / 25g * -Boc-L-Ala: [ ] / 100g * -Cbz: [ ] / 100g * -Fmoc-L-Ala: [ ] 8400 / 25g * -Boc-D-Ala-Me ester: [ ] / 10g * -Boc-L-Ala-Me ester: [ ] / 10g * -Boc--Me: [ ] / 5g * -Boc-Weinreb amide:[ ] / 5g *,-di( n Pr): [ ] 8800 / 1g 2 C L-Arginine (Arg, R) [ ] / 500g * D-Arg: [ ] / 5g * α-bz-et ester-cl: [ ] / 25g * α-boc: [ ] / 5g * α-cbz: [ ] 4600 / 5g * α-boc-δ,ω-dicbz: [ ]15600 / 2.5g * α-fmoc: [ ] / 5g * α-ts-me ester-cl: [ ] / 100g * ω-nitro: [ ] 9000 / 10g * ω-nitro-me ester-cl: [ ] / 25g 2 C L-Asparagine (Asn, ) [ ] * monohydrate [ ] 4800 / 100g * D-Asn-monohydrate: [ ] / 100g * -Ac: [ ] / 5g * -Boc: [ ] / 100g * -Cbz: [ ] 6600 / 10g * -Fmoc: [ ] 5900 / 5g 2 C L-Lysine (Lys, K) [ ] / 100g * L-Lys-2Cl [ ] / 100g * L-Lys-Cl [ ] 7500 /1kg * D-Lys: [ ] / 25g * D-Lys-Cl [ ] / 25g * α-ac: [ ] 9000 / 1g * ε-ac: [ ] / 5g * α-boc: [ ] / 25g * α-boc-ε-fmoc: [ ] / 25g * α-fmoc-ε-boc: [ ] / 25g * ε-boc: [ ] / 5g * α-cbz: [ ] / 5g * (D-)α-Cbz: [ ] / 5g * ε-cbz: [ ] / 50g * α ε-dicbz: [ ] / 25g C update: K.isaki L-Aspartic acid (Asp, D) [ ] 7700 / 500g * D-Asp: [ ] 8300 / 25g * K salt-hydrate: [ ] 5900 / 100g * a salt-monohydrate: [no CAS-o.] / 500g * -Ac: [ ] / 25g * dime ester-cl: [ ] / 25g * dibn ester-ts: [ ] / 25g * -Boc: [ ] / 10g * -Boc-1-Bn ester: [ ] / 25g * -Boc-4-Bn ester: [ ] / 25g * (D-)-Boc-4-Bn ester: [ ] / 25g * -Boc-4-Me ester: [ ] / 5g * -Cbz-1-Me ester: [ ] / 5g * -Cbz-4-Me ester: [ ] / 5g * -Cbz-4- t Bu ester: [ ] / 5g * -Cbz: [ ] 7800 / 25g * -Cbz-anhydride: [ ] / 25g L-Glutamic acid (Glu, E) [ ] 8400 / 1kg * D-Glu: [ ] / 100g * mono a salt-hydrate: [ ] 8100 / 1kg * γ-bn ester: [ ] / 25g * γ-me ester-cl: [ ] / 25g * diet ester-cl: [ ] 9400 / 25g * -Ac: [ ] 8800 / 100g * (D-)-Bz: [ ] / 10g * -(4-aminoBz)-diEt ester: [ ] / 25g * (D-)-Boc-1-Bn ester: [ ] / 25g * -Fmoc-γ- t Bu ester hydrate: [ ] / 5g * -Fmoc-γ- t Bu ester: [ ] / 25g * -(4-nitroBz)-hemihydrate: [ ] / 5g * -phthaloyl: [ ] / 10g * -Cbz: [ ] 7300 / 25g * -Cbz-1-Me ester: [ ] 7600 / 1g * (S)--Cbz-,α-methylidene: [ ] / 5g * -Fmoc-4- t Bu ester: [ ] / 25g * (S)--Cbz-,α-methylidene: [ ] / 5g C S C L-Cysteine (Cys, C) [ ] / 500g * L-Cystine (Cys dimer) [ ] / 500g * Cl salt-hydrate: [ ] / 1kg * Et ester-cl: [ ] / 100g * Me ester-cl: [ ] 4600 / 25g * cystine dime ester-2cl: [ ] / 25g * -Ac: [ ] / 500g * -Ac-Me ester: [ ] / 25g * S-Bz: [ ] / 100g * -Boc-Me ester:[ ] / 25mL * -Cbz-S-: [ ] / 25g *,S-diAc-Me ester: [ ] 9600 / 5g * -Fmoc-S-Tr: [ ] / 5g * S-: [ ] / 5g * S-Tr: [ ] / 5g * S,-carbonyl: [ ] / 5g 2 C L-Glutamine (Gln, Q) [ ] / 500g * α-boc:[ ] / 25g * α-boc-δ-tr: [ ] / 5g * α-fmoc:[ ] 5900 / 5g * α-cbz: [ ] / 25g C L-istidine (is, ) [ ] / 1kg * Cl-hydrate: [ ] / 1kg * D-is-Cl-hydrate: [ ] 7800 / 5g * Me ester-2cl: [ ] / 100g * α-boc: [ ] 9600 / 5g * α-boc- im -Tr: [ ] / 5g * α-fmoc- im -Tr: [ ] / 25g * α, im -diboc-me ester: [ ] / 5g * α-cbz: [ ] 7900 / 5g C L-Leucine (Leu, L) [ ] / 1kg * D-Leu: [ ] / 25g * Me ester-cl: [ ] 8000 / 25g * -Boc: [ ] / 100g * (D-)-Boc:[ ] / 25g * -Boc-Me ester: [ ] / 25mL * -Boc-Weinreb amide: [ ] / 5g * -Cbz: [ ] 8900 / 25mL * -Fmoc: [ ] / 100g * leucinamide-cl: [ ] 7500 / 5g * p-nitroanilide [ ] / 5g L-Proline (Pro, P) [ ] / 1kg C * D-Pro: [ ] 7700 / 5g * Me ester-cl: [ ] / 25g * Bn ester-cl: [ ] / 5g * -Bn-Et ester: [ ] / 5g * -Cbz: [ ] 6300 / 10g * -Cbz-pyrrolidinylamide: [ ] / 5g L-Tryptophan (Trp, W) [ ] / 1kg * D-Trp: [ ] / 100g * Bn ester: [ ] / 5g * Me ester-cl: [ ] / 25g *(D-)Me ester-cl: [ ] / 5g * -Ac-Et-ester: [ ] / 1g * -Boc: [ ] / 100g * (D-)-Boc: [ ] 8100 / 1g * -Boc-Weinreb amide: [ ] / 5g * -Cbz: [ ] / 25g * -Fmoc: [ ] / 25g * -trifluoroacetyl-acylchloride: [ ] / 25g * -Boc: [ ] 9000 / 5g * -Cbz: [ ] 9900 / 25g * -Fmoc: [ ]5900 / 5g * -methoxycarbonyl-me ester: [ ] / 5g C

2 C L-Tyrosine (Tyr, Y) [ ] / 1kg * D-Tyr: [ ] 4600 / 5g * Cl salt: [ ] / 25g * hydrazide: [ ] / 25g * Me ester: [ ] / 100g * Me ester-cl: [ ] 7800 / 25g * α-ac-tyrosinamide: [ ] / 5g * -Ac: [ ] 6100 / 25g * -Ac-Et ester hydrate: [ ] /25g * -Bz-Et ester: [ ] / 25g * -Boc: [ ] / 100g * -Boc--Me: [ ] / 5g * (D-)-Boc--Me: [ ] / 25g * -Boc-Me ester: [ ]19800 / 25g * -Fmoc-- t Bu: [ ] / 5g * -Cbz-hydrate: [ ] / 25g C L-Threonine (Thr, T) [ ] / 1kg * D-Thr: [ ] / 100g * -Bz: [ ] / 5g * -Bz-Me ester [ ] 8200 / 1g * -Boc: [ ] 8700 / 5g * -Boc--Bn: [ ] / 5g * -Boc-Me ester: [ ] / 10g * -Boc-- t Bu: [ ] / 5g * -Cbz: [ ] / 25g * -Cbz-Me ester: [ ] / 5g C L-enylalanine (e, F) [ ] / 1kg * D-e: [ ] / 100g * -Ac: [ ] 6500 / 5g * -Ts: [ ] / 50g * -Ts-acylchloride: [ ] / 25g * -Boc: [ ] / 100g * -ethoxycarbonyl: [ ] / 25g * (D-) -Boc: [ ] / 25g * -Boc-Me ester: [ ] / 25g *,-dime: [ ] / 5g * -Fmoc: [ ] / 25g * Et ester-cl: [ ] / 50g * (D-) Me ester-cl: [ ] / 10g * Me ester-cl: [ ] 7100 / 10g * -Cbz: [ ] / 5g MeS C L-Methionine (Met, M) [ ] / 1kg * D-Met: [ ] / 25g * -Boc: [ ] / 25g * -Boc-Cy 2 salt: [ ] / 25g * (D-)-Boc: [ ] / 25g * -Cbz: [ ] / 25g * Et-ester-Cl: [ ] / 50g * Me-ester-Cl: [ ] / 25g C L-Isoleucine (Ile, I) [ ] / 1kg * -Boc: [ ] / 25g * -Cbz: [ ] / 25g C L-Serine (Ser, S) [ ] / 1kg * D-Ser: [ ] / 25g * Et ester-cl: [ ] 8000 / 5g * Me ester-cl: [ ] 9700 / 25g *(D-)Me ester-cl: [ ] / 25g * -Bn-D-Ser:[ ] / 5g * -Boc--Me: [ ] / 5g * -Boc: [ ] / 100g * (D-) -Boc: [ ] / 5g * -Boc--Bn: [ ] / 25g * (D-) -Boc--Bn: [ ] / 25g * -Boc-Me ester: [ ] / 10g * (D-) -Boc-Me ester: [ ] / 10g * -Cbz: [ ] / 25g * -Cbz-Me ester: [ ] / 10g * (D-) -Cbz-Me ester: [ ] / 10g *,-dibn--tbs-bn ester:[ ] / 10 ml *,-dibn--tbs-me ester:[ ] / 5g *,-dibn-bn ester:[ ] 9500 / 10mL * (D-),-diBn-Me ester:[ ] / 5g *,-dibn-me ester:[ ] / 5g * -Fmoc-- t Bu: [ ] / 5g * -Tr-Me ester: [ ] / 25g * (R)--Cbz-,α-methylidene: [ ] / 5g * (S)--Cbz-,α-methylidene: [ ] / 5g C L-Valine (Val,V) [ ] / 1kg * D-Val: [ ] / 25g * Me ester-cl: [ ] / 50g * (D-)Me ester-cl: [ ] / 5g * Et ester-cl: [ ] / 25g * -Boc--Me: [ ] / 5g * -Boc: [ ] / 100g * (D-) -Boc: [ ] / 25g * -Boc-Weinreb amide: [ ] / 5g * -Boc-Me ester: [ ] / 25mL * -Cbz: [ ] 4000 / 5g * -Fmoc: [ ] 5900 / 5g * (D-)-Fmoc: [ ] / 5g * valinamide-cl: [ ] / 5g C L-enylglycine [ ] / 100g * D-: [ ] 6200 / 100g * (D-)acylchloride-Cl: [ ] / 100g * Me ester-cl: [ ] / 50g * (D-)Me ester-cl: [ ] / 100g * D-phenylglycinamide-Cl: [ ] / 5g * -Boc: [ ] / 5g * (D-) -Boc: [ ] / 5g * -3,5-dinitrobenzoyl: [ ] / 5g * (D-) -3,5-dinitrobenzoyl: [ ] / 5g C L-orvaline [ ] / 10g * D-: [ ] 9800 / 5g * -Boc: [ ] / 25g * (D-)-Boc: [ ] / 5g C L-orleucine [ ] / 10g * D-: [ ] 5900 / 1g * -Cbz: [ ] / 5g * -Fmoc: [ ] / 5g C L-tert-Leucine [ ] / 25g * -Boc: [ ] / 25g * -Cbz-Cy 2 salt: [ ] / 25g C 2 trans-4-ydroxy-l-proline [ ] / 100g * -Ac: [ ] / 10g * -Boc: [ ] / 25g * -Boc-Me ester: [ ] / 5g * -Boc-Bn ether: [ ] / 25g * -Cbz: [ ] / 25g C 2 cis-4-ydroxy-d-proline [ ] / 10g S C D-Penicillamine [ ] / 100g * L-: [ ] / 5g 2 C L-rnithine * Cl salt: [ ] 7800 / 100g * (D-)Cl salt: [ ] / 10g C L-omophenylalanine *Cl-salt: [ ] / 5g 2 L-omoarginine * 2Cl salt:[ ] / 5g C L-omoserine [ ] / 5g C

3 C Pipecolinic acid * (S)--Boc: [ ] / 5g * (R)--Boc: [ ] / 5g * (S)--Cbz: [ ] 16900/ 5g * (R)--Cbz: [ ] / 5g C 2 ipecotic acid * Et ester-l-tartrate salt: [ ] / 10g * -Fmoc: [ ] / 5g I I I Thyroxine [ ] / 5g *a salt-hydrate: [ ] / 5g S C 2 I L-Thioproline [ ] / 100g C C * =, L-DPA [ ] / 500g * =, 2Cl-hydrate: [ ] / 25g * =I, [ ] / 25g * = 2, [ ] / 25g C * hemihydrate: [ ] / 5g 2 C 2 * hydrate: [ ] / 5g [ ] / 5g C 2 [ ] 9000 / 5g * -Cbz: [ ] / 10g * Bn ester-ts: [ ] / 10g * t Bu amide:[ ] / 5g *,-carbamate: [ ] / 5g Me Me * Cl salt: [ ] / 5g * Ts salt: [ ] / 5g 2 C * -Cbz-Me ester: [ ] / 5g * -Tr-Me ester: [ ] 9300 / 5g * (2R,1R): [no CAS o.] / 5g * (2S,1R): [no CAS o.] / 5g C L-Cyclohexyl-Ala [ ] / 5g C L-Me-Ala [ ] / 5g * D-: [ ] / 5g * -Cbz: [ ] / 5g * -Cbz--Me: [ ] / 5g C Cyclohexylglycine * -Boc: [ ] / 5g * (D-)-Cbz: [ ] / 5g C * =, L-: [ ] / 50g * =, D-: [ ] 7100 / 100g * =, L-Me ester-cl: [ ] / 5g * =, D-Me ester-cl: [ ] / 5g * =F, D-: [ ] / 5g [ ] 7000 / 5g C 2 [ ] / 5g 2 C [ ] / 25g * -Cbz: [ ] / 25g 2 C * 2Cl salt: [ ] / 5g * α,γ-carbonyl-γ-cbz: [ ] / 5g C 2 Bz * (1S, 2R)-: [ ] / 5g * (1R, 2S)-: [ ] / 5g C C 2 * (S)-Me ester: [ ] / 5g C C 2 Me * (R): [ ] / 5mL * (S): [ ] / 5g C 2 [ ] / 10g * (S)- n Bu ester: [ ] / 25mL * (R)-Et ester: [ ] / 5g * (S)-Et ester: [ ] / 5g * (S)-Me ester: [ ] / 5g * (S): [ ] / 5g * (R): [ ] / 5g * (S)--Tr: [ ] / 5g

4 * -Cbz: [ ] / 5g -Br [ ] / 5g 2 D-Cycloserine [ ] / 5g C [ ] / 25g -Cl [ ] / 5g -Cl * (R): [ ] / 5g * (S): [ ] / 5g [ ] / 5g

5 > Amino Alcohols Alaninol * (S)-: [ ] / 10g * (R)-: [ ] / 5g * (R)--Boc: [ ] / 5g * (S)--Boc: [ ] / 5g * (S)-,-diBn: [ ] / 5g * (S)--Cbz: [ ] / 5g L-Tryptophanol [ ] / 1g Valinol * (R)-: [ ] / 5g * (S)-: [ ] / 25g * (D-)-Boc: [ ] 7800 / 1g * -Boc: [ ] / 5g * -Fmoc: [ ] / 5g * (R)-,-carbamate: [ ] / 2.5g * (S)-,-carbamate: [ ] / 5g L-enylglycinol [ ] / 5g * D-: [ ] / 25g * L--Bn: [ ] / 5g * L--Boc: [ ] 6800 / 1g * D--Boc: [ ] / 1g * (R)-,-carbamate: [ ] / 5g * (S)-,-carbamate: [ ] / 5g L-Prolinol [ ] / 25g * D-: [ ] / 5g * -Bn: [ ] / 25g * -Boc: [ ] / 5g * (D-)-Boc: [ ] / 1g * -(2-Me-Bz)--Me: [ ] 9700 / 1g * (R)--(2-methoxybenzoyl); [ ] 6700 / 1g * (S)--(2-methoxybenzoyl); [ ] / 5g * (S)--formyl--Me: [ ] / 5g * (S)--Me: [ ] / 25g enylalaninol * (R)-: [ ] / 5g * (S)-: [ ] / 10g * (R)--Boc: [ ] / 5g * (S)--Boc: [ ] / 10g * (R)--Cbz: [ ] / 5g * (S)--Cbz: [ ] / 5g * (S)-,-diBn: [ ] / 5g * (S)--Ts: [ ] / 5g * (R)-,-carbamate: [ ] / 25g * (S)-,-carbamate: [ ] / 25g * (S)-,-carbamate-Ac: [ ] / 5g * (R)-,-carbamate-propionyl: [ ] / 5g * (S)-,-carbamate-propionyl: [ ] / 5g L-Leucinol [ ] / 25g * D-: [ ] / 5g * (D-)-Boc: [ ] 9000 / 1g * -Boc: [ ] / 5g * -Cbz: [ ] / 5g L-Tyrosinol * Cl salt: [ ] 6000 / 1g L-istidinol * 2Cl salt: [ ] / 5g L-tert-Leucinol [ ] / 5g * -Boc: [ ] / 5g orephedrine *(1S,2R)- -dime, -Methylephedrine [ ] 5200 / 1g *(1R,2S)- -dime [ ] 4200 / 1g * -Me--(2-amnoacetyl)-: [ ] / 5g * -dime--bn bromide: [ ] 9800 / 5g * (1R,2S)-.-di n Bu: [ ] / 5g * (1S,2R)-.-di n Bu: [ ] / 5g * (1R,2S)-.-diEt-Cl: [no CAS o.] / 5g * (1S,2R)-.-diEt-Cl: [no CAS o.] / 5g Me Pseudoephedrine *(1R, 2R): [ ] / 25g *(1S, 2S): [ ] / 100g *(1S, 2S)-α-fluoroacetamide: [ ] / 25g *(1R, 2R)-propionamide: [no CAS o.] / 5g *(1S, 2S)-propionamide: [ ] / 5g Me enylephrine * Cl salt: [ ] / 100g * (1R, 2S)-: [ ] / 5g * (1S, 2R)-: [ ] / 5g L-Isoleucinol [ ] / 5g Epinephrine [ ] / 100g * (R)-: [ ] 8600 / 5g * (S)-: [ ] / 5g Bn [ ] / 1g * -Boc: [ ] / 5g [ ] / 5g *-Boc: [ ] / 5g * (D-)-Boc: [ ] / 5g * (L-)-Boc: [ ] / 5g * =, (R,R)-: [ ] / 5g * =, (S,S)-: [ ] / 5g * = 2, (R,R)-: [ ] 8900 / 25g * = 2, (S,S)-: [ ] / 50g * = 2, dichloroacetamide, Chloramphenicol [ ] 9500 / 25g * =SMe, (S,S)-, Thiomicamine: [ ] / 500g

6 S L-Cysteinol * S-Bz: [ ] / 5g * (S)--Boc: [ ] / 5g * (S)--Boc: [ ] / 5g * (1R,1'R): [no CAS o.] / 5g * (1S,1'R): [no CAS o.] / 5g Me 2 Chirald [ ] / 50g Bn [ ] / 5g * (R): [ ] / 5g * (R)-Cl: [ ] / 10g * (R)--Bn: [ ] / 5g * (S)--Bn: [ ] 9600 / 5g * (R)--Boc: [ ] / 5g [ ] / 5g * (R)-Cl salt [ ] / 5g 2 * (R)-: [ ] / 5g * (S)-: [ ] / 5g 2 [ ] / 5g * - t Bu: [ ]18000 / 5g

7 > Acids, Esters C 2 Mandelic acid * (R): [ ] 5500 / 25g * (S): [ ] / 100g * (R)-Ac: [ ] 9500 / 5g * (S)-Ac: [ ] 9000 / 5g * (R)-Bn ester: [ ] / 25g * (S)-Bn ester: [ ] / 25g * (R)-Et ester: [ ] / 25g * (S)-Et ester: [ ] / 25g * (R)-3-Cl: [ ] / 25g * (R)--formyl-acylchloride: [ ] / 5g * (R)-Me ester: [ ] / 5g * (S)-Me ester: [ ] / 5g 2 C C 2 L-Tartaric acid [ ] 3000 / 500g * D-: [ ] / 100g *,'-diallyltartaramide: [ ] / 100g * D-,,','-tetraMe tartaramide: [ ] / 5g *,,','-tetrame tartaramide: [ ] / 25g *,'-dibenzyltartramide: [ ] / 5g *,'-dibenzyl D-tartramide: [ ] 6400 / 1g * dibz-d-tartaric acid:[ ] / 250g * dibz-l-tartaric acid:[ ] / 100g * dipiv-d-tartaric acid:[ ] / 5g * dipiv-l-tartaric acid:[ ] 9700 / 5g * ditoluoyl-d-tartaric acid:[ ] / 100g * ditoluoyl-l-tartaric acid:[ ] 9300 / 25g * dibz-l-tartaric acid monohydrate:[ ] / 500g * D-DMT:[ ] / 25g * L-DMT:[ ] 9100 / 100g * D-DET:[ ] / 500g * L-DET:[ ] / 500g * D-DIPT:[ ] / 50g * L-DIPT:[ ] / 100g * diac-l-tartaric acid anhydride:[ ] / 50g * benzilydene acetal-dime ester: [ ] / 25g * (+)-isopropylidene acetal-dime ester: [ ] 8400 / 5g * (-)-isopropylidene acetal-dime ester: [ ] / 25mL * mono-a salt-hydrate: [ ] / 1kg L-Ascorbic acid [ ] 6400 / 500g * 6-palmitate: [ ] / 100g * 2',3'-isoproplidene acetal: [ ] / 25g * a salt: [ ] 6800 / 1kg Dehydroascorbic acid [ ] / 5g D-Isoascorbic acid [ ] 6700 / 500g *a salt-hydrate: [ ] 4800 / 250g C 2 * (R): [ ] 7300 / 1g * (S): [ ] 8000 / 1g C 2 L-Lactic acid [ ] / 1kg * -Ac: [ ] / 10g * -Ac-lactyl chloride: [ ] / 5g * Bn ester: [ ] / 25mL * Et ester: [ ] 4400 / 500g * I Pr ester: [ ] 4400 / 100g * D-isobutyl ester: [ ] / 25mL * D--Bn: [ ] / 25g * n Bu ester:[ ] / 100mL * dimer lactone: [ ] / 100g * -TBS-Et ester:[ ] / 25mL * (R)-lactamide: [ ] / 50g * (S)-lactamide: [ ] / 50g * (R)-Me ester: [ ] 5900 / 5g * (S)-Me ester: [ ] / 100g * (S)--(phenylcarbamoyl): [ ] / 5g * a salt: [ ] / 50g * (D-)a salt: [ ] / 5g C 2 * =Br (R):[ ] / 50mL * =Br (S):[ ] 8200 / 5g * =Cl (S):[ ] / 5g * =Cl (R)-Me ester:[ ] / 5g C 2 * =Br, (R)-Me ester: [ ] / 5g * =Br, (S)-Me ester: [ ] / 5g * =, (R)-Me ester: [ ] / 5g * =, (S)-Me ester: [ ] / 25g C 2 * =, (S): [ ] / 5g * =Br, (R): [ ] / 25g * =Br, (S): [ ] / 25g C 2 [ ] 4900 / 1g C 2 [ ] / 100g * Me ester: [ ] / 50g C 2 * =Br, (R)-Et ester: [ ] / 5g * =Cl, (R)-Et ester: [ ] / 5g * =Cl, (S)-Et ester: ] / 5g * =C, (R)-Et ester: [ ] / * =, (R)-Et ester: [ ] / 5g * =, (S)-Et ester: [ ] / 5g * =, (R)-a salt: [ ] 8900 / 1g * =, (R)-Me ester: [ ] / 25g C 2 [ ] / 5g C 2 * (R)-Me ester: [ ] / 5g * (S)-Me ester: [ ] / 5g C 2 * (R): [ ] / 1g * (S): [ ] / 1g C 2 * D-: [ ] / 5g * L-: [ ] / 5g * (R)-Bn ester: [ ] / 5g * (S)-Bn ester: [ ] / 5g * (S)-Me ester: [ ] / 100g C 2 * (R)-Et ester: [ ] / 1kg C 2 [ ] / 5g C 2 * (R): [ ] / 5g * (S): [ ] / 5g C 2 * (R): [ ] / 5mL * (S): [ ] / 5mL

8 2 C C 2 Malic acid * (R): [ ] 6400 / 5g * (S): [ ] 6700 / 100g * (S)-dia salt hydrate: [ ] / 25g * (R)-diiMe ester:[ ] / 5mL * (S)-diMe ester:[ ] / 25g * (R)-diisopropyl ester:[ ] / 25mL * (S)-diisopropyl ester:[ ] / 25mL * (R)-acetonide:[ ] / 25g * (S)-acetonide:[ ] / 25g 2 C C 2 Citramalic acid * (R):[ ] / 5g * (S):[] / 5g 2 C C 2 * (R): [ ] 9000 / 5g * (S): [ ] / 5g * (R)-diMe ester:[ ] 8000 / 5g 2 C [ ] / 10g C 2 Me C 2 * (R): [ ] / 25g * (S), aproxen: [ ] 9000 / 25g C 2 C 2 * (R): [ ] / 5g *(S): [ ] / 5g * (S): [ ] / 25g *(R)-Et ester: [ ] / 1g 2 C C 2 * (1R,3S): [ ] / 500g * (1S,3R): [ ] / 1g Cl 3 C Cl 3 C [ ] 6800 / 5g [ ] / 25g 2 C [ ] 9100 / 1g 2 C Ac C 2 Me C 2 Et [ ] / 25mL [ ] / 5g C 2 (S)-Ibuprofen [ ] / 10g C 2 2 [no CAS o.] / 100g C 2 * (R): [ ] / 5g * (S): [ ] / 5g Pantolactone * (R): [ ] 4400 / 25g * (S): [ ] / 5g * (R)-acrylate: [ ] / 5g Me 2 C [ ] / 10g Ac [ ] / 25g [ ] / 5g * -cis: [ ] / 1g * -trans: [ ] / 5g Me * (R): [ ] / 25g * (S): [ ] / 25g Me Me C 2 Me C 2 Me * (S,S,S,S): [ ] / 5g * (R,R,R,R): [ ] / 25g Me C 2 Me C 2 Me Me [no CAS o.] / 5g

9 > Sugers D-Galactose [ ] / 1kg * pentaacetate: [ ]30200 / 100g * pentapivaloate: [ ] / 5g *(1,2)-(3,4)-diisopropylidene: [ ] / 5g D-Glucose: [ ] / 5kg * L-: [ ] / 25g * =α-me, [ ] / 25g * =β-, [ ] / 5g Bz Bz Bz Bz * =α-bz, [ ] / 5g * =α-br, [ ] / 5g D-Glucosamine * hydrate: [ ] / 1kg * -Ac: [ ] / 500g * -Boc: [ ] / 25g * pentaacetate: [ ] / 5g Ac Ac Et [ ] / 5g Ac Ac R * R=Me: [ ] / 25g * R=Allyl: [ ] / 5g * R=: [ ] / 5g * R=2-nitrophenyl: [ ] / 25g * R=4-nitrophenyl, hydrate: [ ] / 5g Ac Ac * =α-ac, [ ] 6500 / 100g * =β-ac, [ ] / 500g * =α-br, [ ] / 5g * =β-allyl, [ ] / 1g * =β-s, [ ] / 5g * =β- n C 8 17, [ ] / 5g Bn Bn Bn Bn * =β- i Pr, [ ] / 5g * =α-trichloroacetimidate, [ ] / 5g Ac Ac Ac Cl Ac [ ] / 5g Allyl [ ] / 5g Ac Ac [ ] / 5g CCF 3 D-Galactal * triacetate: [ ] / 5g * tribenzoate:[ ] / 5g [ ] / 25g Me [ ] / 5g a D-Galacturonic acid-a [ ] / 25g [ ] / 10g * =, [ ] / 100g * =α-me, [ ] / 1kg [ ] 5400 / 1kg * =β-, [ ] / 25g * =α--(4-nitrophenyl), [ ] / 25g * =β- n C 8 17,[ ] / 100g D-Gluclonic acid [ ] / 100g [ ] 7800 / 1g S S [ ] / 5g D-Glucal [ ] / 10g * tribn: [ ] / 5g * triac: [ ] / 100g * tritbs: [ ] / 5g 2 D-Gluclonamide [ ] / 25g

10 L-Mannose [ ] / 5g L-Arabinose [ ] / 100g * D-: [ ] / 100g * L-Arabitol: [ ] / 100g * D-Arabitol: [ ] / 250g D-Mannnosamine *Cl salt: [ ] / 5g Lyxose * D-: [ ] 6300 / 5g * L-: [ ] / 25g Ac Ac Ac [ ] / 5g Et D-Fructose [ ] 5200 / 1kg * =, D-ylose [ ] / 1kg * L-ylose: [ ] / 25g * =β-me, [ ] 7400 / 25g Cl [ ] / 5g Br D-Fucose [ ] / 5g * L-: [ ] / 100g Ac Ac Ac * D-: [ ] / 5g * L-: [ ] / 5g CCl 3 α-chloralose [ ] / 1kg CCl 3 β-chloralose [ ] 6600 / 100g [ ] / 5g [ ] 6600 / 25g Me [ ] / 5g [ ] / 5g [ ] / 50g Bz Ms Ac [ ] 7100 / 5g C 2 * hydrate: [ ] / 100g * D-: [ ] / 25g * L-: [ ] / 25g *monohydrate: [ ] / 25g [ ] / 1kg [ ] / 25g [ ] 9800 / 25g C 2 D-Saccharic acid * K salt: [ ] / 500g

11 D-Mannitol [ ] 4300 / 1kg * hexaac: [ }13700 / 100g * 1,2-5,6-diisopropylidene: [ ] / 25g * 1,2-isopropylidene: [ ] / 1g * 3,4-isopropylidene: [ ] / 5g * 1,2-3,4-dicyclohexylidene: [ ] / 25g Ac Ac Ac Ac Ac D-Ribose [ ] / 100g * tetraac: [ ] / 25g * 1-Ac-2,3,5-triBz: [ ] / 10g Ac * hydrate: [ ] / 10g * R=Me, [ ] / 1kg * R=Et, [ ] 5800 / 100g (p- 2 -Bz) Ac [ ] / 5g R [ ] 8500 / 1g * =, 2-Deoxyribose * =Me, [ ] / 5g * a salt: [ ] 2800 / 1kg ct [ ] / 50g Me D-Sorbitol [ ] 4200 / 1kg * hexaacetate: [ ] / 100g * D-: [no CAS o.] / 5g [ ] / 5g [ ] / 100g * L-: [no CAS o.] / 5g D-Threitol * D-2,3--benzylidene: [ ] 7100 / 1g * L-2,3--benzylidene: [ ] / 5g * D-2,3--benzylidene-1,4-diTs: [ ] / 5g * L-2,3--benzylidene-1,4-diTs: [ ] / 5g * D-2,3--isopropylidene: [ ] 9300 / 1g D-Isosorbide [ ] / 500g Isomannide [ ] / 100g [ ] / 1kg [ ] / 25g C C 2 Me [ ] / 5g

12 > Alcohols Glycidol * (R): [ ] / 5g * (S): [ ] / 5g * (R)-butyrate: [ ] / 5g * (S)-butyrate: [ ] / 5g * (R)-Me ether: [ ] / 5g * (S)-Me ether: [ ] / 5g * (R)-m-nitrobenzenesulfonate: [ ] / 25g * (S)-m-nitrobenzenesulfonate: [ ] / 25g * (R)-p-nitrobenzoate: [ ] 9600 / 1g * (S)-p-nitrobenzoate: [ ] 9700 / 1g * (R)-tosylate: [ ] / 25g * (S)-tosylate: [ ] / 25g * (R)-Tr ether: [ ] / 5g * (S)-Tr ether: [ ] / 5g * (S)-TBS ether: [ ] / 5g * (R)-p-nitrobenzoate: [ ] / 1g * (S)-p-nitrobenzoate: [ ] / 5g [ ] / 5g Br * (R):[ ] / 5g * (S):[ ] / 5g Cl * (R):[ ] / 5g * (S):[ ] / 5g * (R): [ ] / 5g * (S): [ ] / 5g * (S): [ ] / 5g * (R): [ ] / 5g * (R): [ ] / 5g * (S): [ ] / 5g F [ ] / 25g Br * (R): [ ] 7100 /1g * (S): [ ] 5700 / 1g [ ] 3900 / 10g * Ms ester: [ ] / 5g n-c 6 13 * (R): [ ] / 10g * (S): [ ] / 10g n-c 7 15 * (R): [ ] / 5g * (S): [ ] / 5g n-c 8 17 [ ] / 5g n-c 9 19 [ ] / 5g Cl * (R): [ ] / 5g * (S): [ ] / 5g * (R): [ ] / 25g * (S): [ ] / 25g * (R)-1-(4-F-)ether:[ ] / 5g * (S)-1-(4-F-)ether: [ ] / 5g * (R)-carbonate: [ ] / 25g * (S)-carbonate: [ ] / 25g Bn [ ] / 5g * (R)-BIL: [ ] / 10g * (S)-BIL: [ ] / 10g * (R)-diAc: [ ] / 25g * (R)-diTs: [ ] / 25g * (S)-diTs: [ ] / 25g Cl n-c 6 13 * (R):[ ] / 25g * (S):[ ] / 25g [ ] / 5g * (R)- 8 -BIL [ ] / 5g * (S)- 8 -BIL [ ] / 1g Ts ydrobenzoin * (R,R): [ ] / 25g * (S,S): [ ] / 25g * (R): [ ] 7100 / 1g * (S): [ ] 9100 / 1g * (S)-2-tosylate: [ ] / 1g Bn [ ] / 5g * (R):[ ] 8700 / 1g * (S): [ ] / 1g Me * (R):[ ] / 5g * (S):[ ] / 5g Bn [ ] / 25g [ ] / 5g Ac [ ] / 5g [ ] / 1g * (R):[ ] / 5g * (S):[ ] / 5g * (R,R):[ ] / 5g * =Br [ ] / 5g * =Cl [ ] / 5g * (R): [ ] / 5g * (S): [ ] / 25g

13 > Amines enethylamine * (R):[ ] / 100mL * (S): [ ] / 100mL * (S)--Bn: [ ] / 50mL * (R)--Bn: [ ] / 50mL * (S)--Allyl: [ ] / 10mL * (R)-4-Cl: [ ] / 5g * (S)-4-Cl: [ ] / 5g * (R)--Me: [ ] / 5g * (S)--Me: [ ] / 5g * (R)-,-diMe: [ ] / 5g * (S)-,-diMe: [ ] / 5g * (R)--3,5-dinitrobenzoyl: [ ] /1g * (S)--3,5-dinitrobenzoyl: [ ] / 5g * (R)-phenylglyoxylamide: [ ] / 5g * (R)-monophthalamide: [ ] / 1g * (S)-monophthalamide: [ ] 4300 / 1g * (R)-monosuccinamide: [ ] / 5g * (S)-monosuccinamide: [ ] / 5g * (R)-trifluoroacetyl: [ ]18100 / 50g * (S)-trifluoroacetyl: [ ]17400 / 50g 2 2Cl * (R)-: [ ] / 1g * (S)-: [ ] / 1g * (R): [ ] / 5g * (S): [ ] / 5g * =Br, (R): [ ] / 5g * =Me, (R): [ ] / 1g * =Me, (S):[ ] / 1g * =Me, (S): [ ] / 25g * = 2, (R)-Cl: [ ] 6600 / 1g * = 2, (S)-Cl:[ ] 5700 / 1g 2Cl [ ] / 10g 2Cl [ ] / 10g * (R): [ ] 6800 / 5g * (S): [ ] 9000 / 5g [ ] / 5g * (S)--Bn-Cl: [ ] / 5g 2 [ ] 8500 / 500g * acetate: [ ] / 25g * (R,R): [ ] / 10g * (S,S): [ ] / 10g * (R,R)-Cl: [ ] / 5g * (S,S)-Cl: [ ] / 5g * (R): [ ] / 25g * (S): [ ] / 5g * -Boc:[ ] 9800 / 1g * (R)-BIAMIE: [ ] / 1g * (S)-BIAMIE: [ ] / 1g 2 * (R,R):[ ] / 5g * (S,S):[ ] / 1g * (R,R)-L-tartrate salt:[ ] / 10g * (S,S)-D-tartrate salt:[ ] / 10g * (R,R)-,'-diTs:[ ] / 5g * (S,S)-,'-diTs:[ ] / 5g * (R,R)-,'-diTf:[ ] / 5g 2 * (R,R): [ ] / 1g [no CAS o.] / 5g * (R)-2Cl: [ ] 6400 / 1g * (S)-2Cl: [ ] 9800 / 1g [ ] 9600 / 1g (-)-Sparteine [ ] / 100mL *sulfate-hydrate: [ ] / 100g Cl S (-)-Tetramisole [ ] 6700 / 10g

14 > itrile, Isonitrile, Isocyanate, Sulfur 2 S Bn Ts S S * (R,R): [ ] / 5g * (S,S): [ ] / 5g [ ] / 5g [ ] / 5g [ ] / 5g C * =, (R)-Mandelonitrile [ ] / 5g * =Cl, (R): [ ] / 5g * =Me, (R): [ ] / 5g C Cl [ ] / 5g C * (R): [ ] / 5g * (S): [ ] / 1g C * (R): [ ] / 5g * (S): [ ] / 5g C [ ] / 10g S [ ] / 5g > Ketones, alides, Epoxides, etc... [ ] / 5g [ ] / 5g * (R):[ ] / 25g * (S):[ ] / 25g * (R):[ ] / 5g * (S):[ ] / 5g * (R):[ ] / 25g * (S):[ ] / 25g Ac Cl [ ] / 25g [ ] / 5g I Cl Epichlorohydrin * (R):[ ] / 25g * (S):[ ] / 25g * (R,R): [ ] / 5g * (S,S): [ ] / 5g Cl * (S): [ ] / 5g * (R): [ ] / 5g

15 > atural Products C (+)-Pulegone [ ] / 100mL (85%) Dihydrocarveol [ ] / 25mL Perillaldehyde * (R): [ ] / 5mL * (S): [ ] / 25g C 2 Isopulegol * (+): [ ] / 1mL * (-): [ ] / 5mL * (R)-Carvone [ ] / 500mL * (S)-Carvone [ ] 7800 / 25mL Carvone hydrate [ ] 7300 / 1g Perillic acid * (S): [ ] / 5g Isomenthol [ ] / 1kg * chloromethyl ther: [ ] / 5g Carveol (mix) [ ] / 50g * acetate: [ ] / 10g * propionate: [ ] / 25g Limonene * (R): [ ] 5100 / 500mL * (S): [ ] / 250g [ ] / 50g Limonene oxide * (+)-mixture: [ ] / 250 g * (-)-mixture: [no CAS o.] / 250g Perillyl alcohol * (R): [ ] 9500 / 1g * (S): [ ] / 50g Menthol * (-)-: [ ] / 500g * (+)-: [ ] / 50g * (-)-menthoxyacetyl chloride: [ ] / 5g * (+)-menthoxyacetic acid: [ ] / 5mL * (-)-menthoxyacetic acid: [ ] / 10g * (-)-acetate: [ ] 8800 / 100mL * (+)-acetate: [ ] / 5mL * (-)-chloride: [ ] / 10g * (-)-chloroformate: [ ] / 100g * (+)-chloroformate: [ ] / 25mL] * (-)-chloromethyl ether: [ ] / 10g * (+)-chloromethyl ether: [ ] / 5g S Tol Menthone [ ] / 100g eomenthol [ ] / 25g * (1S)-acetate: [ ] 9500 / 1g * (1R)-acetate: [ ] / 1g * (R,S,R,S S )-: [ ] / 10g * (S,R,S,R S )-: [ ] / 10g 2-Carene [ ] / 25mL 3-Carene [ ] / 5mL (+)-ootkatone [ ] / 5g (>85%) * (1R)-: [ ] / 10g * (1S)-: [ ] / 5g

16 * (+)-Camphene [ ] / 1kg * (-)-Camphene [ ] / 1kg * (+)-Camphor [ ] / 500g * (-)-Camphor [ ] / 10g * (S)-Camphorquinone [ ] / 5g * (R)-Camphorquinone [ ] 9600 / 5g * (R)-Fenchone [ ] / 250g * (S)-Fenchone [ ] / 100mL (R)-Fenchol [ ] / 500g Isopinocampheylamine * (-): [ ] / 5g * (+): [ ] / 5g Isopinocampheol * (-): [ ] / 100g * (+): [ ] / 100g (-)-trans-myrtanol [ ] / 10g C (+)-cis-myrtanylamine [ ] / 10g (1R)-opol [ ] / 1L * Bn ether: [ ] / 100g (1R)-Myrtenal [ ] / 50g (1R)-Myrtenol [ ] / 100g (1R)-opinone [ ] / 5g (+)-Longifolene [ ] / 25mL * (+)-α-pinene: [ ] / 500mL * (-)-α-pinene: [ ] / 500mL Verbenone [ ] / 50g (-)-β-pinene [ ] / 1L Verbenol [ ] / 25g 3 S * (S)-CSA [ ] / 500g * (R)-CSA [ ] / 100g * (S)-CSAamide [ ] / 5g * (R)-CSAamide [ ] / 5g * (R)-CSA- 3 salt [ ] / 50g * (S)-CSAchloride [ ] / 100g * (R)-CSAchloride [ ] / 100g C 2 3 S Br [ ] / 1g Br [ ] 5300 / 5g CF 3 * (+)-: [ ] / 5g * (-)-: [ ] / 1g * (R,R,R): [ ] / 5g * (S,S,S): [ ] / 5g CF 2 CF 2 CF 3 * (+)-: [ ] / 5g * (-)-: [ ] / 5g * (R)-: [ ] / 1g * (S)-: [ ] / 500g * (S)-Ac: [ ] / 500g * (1R): [ ] / 5g * (1S): [ ] / 5g * (S):[ ] / 5g * (S)-acyl chloride:[ ] / 5g 3 S Br * 3 salt: [ ] 9800 / 25g C 2 [ ] / 5g Br Br [ ] 7100 / 5g

17 Citronellal * (R):[ ] / 5g * (S):[ ] / 5g C Citronellene [ ] / 100mL Citronellic acid * (R):[ ] / 5g * (S):[ ] 9700 / 1g C 2 Citronellol * (R):[ ] / 1g * (S):[ ] / 5g (-)-Thujone [ ] / 25g Cl Pilocarpine [ ] / 50g S C 2 Me Me Strychnine [ ] / 100g Brucine [ ] 7800 / 25g * hydrate: [ ] / 100g * sulfate hydrate: [ ] 6000 / 25g Biotin [ ] / 25g Br * (R):[ ] / 5g * (S):[ ] / 25g Linalool [ ] / 100mL C 2 Chinchonidine [ ] / 100g Chinchonine [ ] / 250g D-Quinic acid [ ] / 100g Me Me Quinine [ ] / 50g Quinidine [ ] / 50g

18 > Comment 実用性のある価格帯を考慮し 1g あたり 円程度までの試薬を集めました 合成素子としての有用性に欠ける不斉触媒 不斉配位子 キラルアンモニウム塩 オリゴペプチド オリゴ糖などの縮合系化合物 複雑な天然物は除いてあります 価格はアルドリッチカタログ 記載の価格です ( 単位 : 円 ) 他社のほうが安い場合も少なからずあるので 注文前に Ald 以外のカタログもチェックしてみて下さい 高めのキラル試薬 市販スケールが小さいもの (1~5g) が大量に欲しくなったときは Scifinder などで調べてみて 自分で合成するというのも一つの策です CAS o. の若いものなどは 効率的合成法が確立されている場合も少なくありません 構造式はすべて手入力なので誤りが相当量あると思われます 自己責任で使用して下さい 誤りを見つけた場合は制作者 ([email protected]) までご一報頂けると幸いです Aldrich Advanced Search も便利です ご活用下さい

ウェブ23Brev2

ウェブ23Brev2 23B 23B.1 23B.1.1 23B.1.2 23B.2 23B.2.1 23B.2.2 a b 23B.3 23B.3.1 23B.3.2 23B.4 23B.4.1 23B.4.2 23B.4.3 23B.5 23B.5.1 23B.5.2 23B.6 23B.6.1 a b c Edman d e 23B.6.2 23B.6.3 23B.7 23B.7.1 a b c 23B.7.2 23B.7.3

More information

スライド 1

スライド 1 タンパク質 ( 生化学 1) 平成 29 年 4 月 20 日病態生化学分野 分子酵素化学分野教授 山縣和也 生化学 1のスケジュール 4 月 20 日 講義開始 6 月 1 日 中間試験 9 月 25 日 生化学 1 試験 講義日程 内容は一部変更があります 講義資料 ( 山縣 吉澤分 ): 熊本大学病態生化学 で検索 ID: Biochem2 パスワード :76TgFD3Xc 生化学 1 の合否判定は

More information

スライド 1

スライド 1 生化学への導入 平成 30 年 4 月 12 日 病態生化学分野教授 ( 生化学 2) 山縣和也 生化学とは 細胞の化学的構成成分 およびそれらが示す化学反応と代謝機序を取り扱う学問 ハーパー生化学 生化学 1 生化学 2 生化学 炭水化物 / 糖 脂質 アミノ酸について勉強します 糖 脂質生化学 2 脂質 アミノ酸 核酸 生化学 1 生化学と医学は密接に関係する 炭水化物 脂質 生化学 蛋白質 核酸

More information

<4D F736F F F696E74202D2091E682508FCD E836D8E5F82C6835E E8EBF205B8CDD8AB B83685D>

<4D F736F F F696E74202D2091E682508FCD E836D8E5F82C6835E E8EBF205B8CDD8AB B83685D> 生物有機化学 教科書 : マクマリー 生物有機化学生化学編 rganic and biological chemistrybiochemistry 生物 ( 生命 ) をより深く理解する 分子レベルで = 有機化学的に 地球の凄さ水 + 空気の世界 ( 2, 2 ) 水 : 酵素反応の溶媒 ( 反応の場を提供 ) ものを溶かす ( 物質によって溶解性は違う ) Why? 水 : 酵素反応の溶媒 (

More information

糖鎖関連試薬糖質データシートカタログ

糖鎖関連試薬糖質データシートカタログ Table of Contents Table of Contents /...1 The Functional ligosaccharides Chain /...2 TCI Website /...4 Catalog Usage Abbreviations Used in the Catalog /...6 Carbohydrates / Allose...7 Arabinose...8 Erythrose...9

More information

島津ジーエルシー総合カタログ2017【固相抽出】

島津ジーエルシー総合カタログ2017【固相抽出】 アミノ酸分析キット 固https://solutions.shimadzu.co.jp/glc 241 EZ:faast ( イージーファースト ) LC/MS LC/MS/MS GC/FID GC/MS 分析可能な 60 種以上の脂肪族 芳香族アミノ酸 Chemical Name Abbreviation LOD (nmol/ml) S/N 3:1 FID MS Alanine ALA 1 0.1

More information

Perl + α. : DNA, mrna,,

Perl + α. : DNA, mrna,, 2009 Perl + α. : DNA, mrna,, DNA .. DNA A C G T DNA 2 A-T, C-G DNA NH 2 NH 2 O - O O N P O - O CH 2 O N N O - O P O CH 2 O N O - O O P O NH 2 O - O - N CH 2 O N O OH OH OH DNA or RNA (U) (A) (G) (C)

More information

1_alignment.ppt

1_alignment.ppt " " " " n " n n " n " n n n " n n n n " n LGPSSKQTGKGW-SRIWDN! + +! LN-ITKSAGKGAIMRLGDA! " n -------TGKG--------!! -------AGKG--------! " n w w w " n w w " " " 11 12 " n w w w " n w w A! M! O! A!

More information

HILIC UPLC /QTof MS Giuseppe Paglia, 1 James Langridge, 2 and Giuseppe Astarita 3 Center for Systems Biology, University of Iceland, Iceland; 2-3. Wat

HILIC UPLC /QTof MS Giuseppe Paglia, 1 James Langridge, 2 and Giuseppe Astarita 3 Center for Systems Biology, University of Iceland, Iceland; 2-3. Wat HILIC UPLC /QTof MS Giuseppe Paglia, James Langridge, 2 and Giuseppe Astarita 3 Center for Systems Biology, University of Iceland, Iceland; 2-3. Waters Corporation, Manchester, UK and Milford, MA, USA

More information

™·”õ/sec3_p63_84/fiü“eflÅ

™·”õ/sec3_p63_84/fiü“eflÅ Section3 64 1 65 Section 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 1 Babara E. Ainsworth et al. Med. Sci. Sports. Exevc.1993 66 67 Section 3 1 10 9 8 1 2 3 4 7 6 5 6 7 5 1 2 3 4 68 69 Section 3 2 70 Section 3

More information

狂牛病調査第2巻1章,2章.doc

狂牛病調査第2巻1章,2章.doc 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 2.1 A LD50/30mg () 10 ND 1 2.8 ND ND ND 11 ND 2.3 1.0 ND ND 11 ND ND 1.3 1.7 ND 13 ND

More information

P 1 Linalool リナロール % Terpinen-4-OL テルヒ ネン-4-ol % γ-terpinene γ-テルヒ ネン 8.068% Myrcene ミルセン 6.425% α-pinene α-ヒ ネン 5.498% Limonene リモネン 3.93

P 1 Linalool リナロール % Terpinen-4-OL テルヒ ネン-4-ol % γ-terpinene γ-テルヒ ネン 8.068% Myrcene ミルセン 6.425% α-pinene α-ヒ ネン 5.498% Limonene リモネン 3.93 P 1 Linalool リナロール 45.680% Terpinen-4-OL テルヒ ネン-4-ol 10.740% γ-terpinene γ-テルヒ ネン 8.068% Myrcene ミルセン 6.425% α-pinene α-ヒ ネン 5.498% Limonene リモネン 3.930% Paracymene ハ ラシメン 3.500% α-terpinene α-テルヒ ネン 3.377%

More information

Polyoxometalateが有するcysteine検出能の検討及びジスルフィド結合形成反応への展開

Polyoxometalateが有するcysteine検出能の検討及びジスルフィド結合形成反応への展開 チオールを特異的に酸化し 発色する 山形大学理工学研究科バイオ化学工学専攻准教授今野博行 金属酸化物クラスターアニオン ポリオキソメタレート Polyoxometalate (POM) 金属元素に酸素が6個配位した MO6を基本骨格とする金属酸化物 1 nm クラスターアニオン MO6 (octahedron) ( PxMyOz )n 構造 構成元素 対カチオン等を 制御することで 様々な機能性を

More information

Microsoft PowerPoint - GC懇(GLS宮川) [互換モード]

Microsoft PowerPoint - GC懇(GLS宮川) [互換モード] スローフードとその網羅的分析法 (slow food) ジエルサイエンス ( 株 ) ジーエルサイエンス ( 株 ) 宮川浩美 スローフードを攻めの農業の一つに ~ フレーバー ( 広義では香りと味 ) と機能 ~ グルコバニリン 糖 糖 脂質 前駆体 アミノ酸 生体 3MH-S-cys 3MH-S-glutS TCA 回路 3-MH( メルカフ トヘキサノール ) 香り 酵素唾液 味 舌ざわり 官能試験

More information

(Quality of Life; QL) QL (Nerve Growth Factor; NGF) NGF PC12 6- (6-HITC) NGF NGF NGF PTP1B 6-HITC PTP1B NGF PTP1B 6-HITC PTP1B 6-HITC NGF 6-HITC 6-HITC in vivo 464-8601 Tel: 052-789-4126 20-Hydroxyecdysone

More information

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

第十四改正日本薬局方第二追補

第十四改正日本薬局方第二追補 461 3 3 3 5 5 6 6 10 18 19 79 81 101 113 127 133 139 145 147 152 153 156 158 165 3 19 20 21 22 22 23 24 25 26 26 27 28 29 29 30 31 dl 32 dl 33 34 34 36 36 37 38 38 38 39 40 42 42 42 43 44 45 46 46 47 48

More information

untitled

untitled 1 2 3 4 2007101 20129 5 20123 6 2.30 1.91 7 http://www.yuchokampo.go.jp/release/pdf/12_disclosure_06_hoken_sankou2.pdf http://www.jili.or.jp/research/factbook/xls/tou6.xls 8 http://www.jcia.or.jp/pdf/pdf_files/fb_1_2012.pdf

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

More information

Microsoft Word - 化学構造式集 doc

Microsoft Word - 化学構造式集 doc 酸素官能のアミノ化合物 (xygen-function amino-compounds.) (A) アミノアルコール並びにそのエーテル及びエステル並びにこれらの塩 (Amino-alcohols, their ethers and esters, salts thereof) (1) モノエタノールアミン (Monoethanolamine) (2) ジエタノールアミン (Diethanolamine)

More information

A-2 cyclopropane cyclobutane cyclopentane cyclohexane cycloheptane cyclooctane methylc

A-2 cyclopropane cyclobutane cyclopentane cyclohexane cycloheptane cyclooctane methylc ethene H 2 H 2 169 104 propene H 2 HH 3 185 47 1 1-butene H 2 HH 2 H 3 185 6.3 11-pentene H 2 H(H 2 ) 2 H 3 138 30 0.641 11-hexene H 2 H(H 2 ) 3 H 3 140 64 0.673 11-heptene H 2 H(H 2 ) 4 H 3 119 94 0.697

More information

2 2 MATHEMATICS.PDF 200-2-0 3 2 (p n ), ( ) 7 3 4 6 5 20 6 GL 2 (Z) SL 2 (Z) 27 7 29 8 SL 2 (Z) 35 9 2 40 0 2 46 48 2 2 5 3 2 2 58 4 2 6 5 2 65 6 2 67 7 2 69 2 , a 0 + a + a 2 +... b b 2 b 3 () + b n a

More information

Microsoft Word - 4NMR2.doc

Microsoft Word - 4NMR2.doc 4 NMR 4.1 Zeeman 1, 13 C, 19 F, 31 P NMR 1 13 C 1/2 4.1 7%&'- 89:;'

More information

contents

contents contents 1 4 8 10 12 14 1. 2. 78 79 16 17 18 20 21 21 22 23 23 24 26 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 1. 2. 3. 4. 5. 6. 7. 8. 9. 28 30 30 32 34 35 36 36 45 46 48 52 60 69 70 71 71 72 74 76 76 1. 2. 3.

More information

日本調理科学会誌 Vol. 45,No. 1,19~24(2012) ノート しょうゆと糖の加熱反応物による乳化作用について Emulsification Intensity of Glucose Supplemented Soy Sauce by Heating 高田優子 * 鈴木宗治 ** 内田

日本調理科学会誌 Vol. 45,No. 1,19~24(2012) ノート しょうゆと糖の加熱反応物による乳化作用について Emulsification Intensity of Glucose Supplemented Soy Sauce by Heating 高田優子 * 鈴木宗治 ** 内田 日本調理科学会誌 Vol. 45,No. 1,19~24(2012) ノート しょうゆと糖の加熱反応物による乳化作用について Emulsification Intensity of Glucose Supplemented Soy Sauce by Heating 高田優子 * 鈴木宗治 ** 内田孝雄 * 三枝維彦 * Yuko Takata Soji Suzuki Takao Uchida Tsunahiko

More information

untitled

untitled 1 1 2 CADLIVE E-CELL 3 GEM CE/MS MGF WT MGF 4 2 WT E-Cell MASK 5 CE-MS, CE- TOFMS LC-MS 24, 5 9 2 0 6 3 CE-MS CE MS Soga, T. et al. (2002) Anal Chem. 74, 2233-2239 7 CE-MS 859 452, 269, 86 8 4 LC-MS 9

More information

Agilent Infinity ELSD ELSD ( ) ( ºC ) W x D x H mm LED ELSD ELSD ELSD UV UV LC/MS RSD % Column: Agilent Pursuit C8, x.6 mm, µm Eluent: Water: Acetonit

Agilent Infinity ELSD ELSD ( ) ( ºC ) W x D x H mm LED ELSD ELSD ELSD UV UV LC/MS RSD % Column: Agilent Pursuit C8, x.6 mm, µm Eluent: Water: Acetonit Agilent Infinity ELSD Agilent 6 Infinity ELSD Agilent 9 Infinity ELSD 6 8 ELSD 9 LC/MS ELSD Agilent Infinity ELSD ELSD ( ) ( ºC ) W x D x H mm LED ELSD ELSD ELSD UV UV LC/MS RSD % Column: Agilent Pursuit

More information

ŁRُ•ñŁŁŁ‘

ŁRُ•ñŁŁŁ‘ 16 11 5 25mg 14 11 18 1 25mg 1 150,000 934 1 2 : 1-235-tumor necrosis factor receptor (human) fusion protein with 236-467-immunoglobulin G1 (human γ1-chain Fc fragment), dimmer : : 1 235 236 467 G 1 γ1

More information

64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () m/s : : a) b) kg/m kg/m k

64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () m/s : : a) b) kg/m kg/m k 63 3 Section 3.1 g 3.1 3.1: : 64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () 3 9.8 m/s 2 3.2 3.2: : a) b) 5 15 4 1 1. 1 3 14. 1 3 kg/m 3 2 3.3 1 3 5.8 1 3 kg/m 3 3 2.65 1 3 kg/m 3 4 6 m 3.1. 65 5

More information

/ 3 1 / 3 / 3 1 /

/ 3 1 / 3 / 3 1 / 8-18-29 3 291415 297 1-11-4 3/31/ 3/31/ 29 8 22 29 1 17 24 8-1 29 [1] PCB [2] HCB [3] [4] [5] DDT [6-1] p,p'-ddt [6-2] p,p'-dde pg/l ( ) nd 2,4 (46/47) 2.9 18 (47/47) 84 12 pg/g-dry ( ) nd 61, (61/62)

More information

Stereoelectronic Effect

Stereoelectronic Effect node anti bonding M ( σ* ) A A : bonding M ( σ ) A: atomic orbital M: molecular orbital node anti bonding M filled orbital of molecular 1 M bonding M vacant orbital of molecular 2 LUM LUM (lowest unoccupied

More information

zz + 3i(z z) + 5 = 0 + i z + i = z 2i z z z y zz + 3i (z z) + 5 = 0 (z 3i) (z + 3i) = 9 5 = 4 z 3i = 2 (3i) zz i (z z) + 1 = a 2 {

zz + 3i(z z) + 5 = 0 + i z + i = z 2i z z z y zz + 3i (z z) + 5 = 0 (z 3i) (z + 3i) = 9 5 = 4 z 3i = 2 (3i) zz i (z z) + 1 = a 2 { 04 zz + iz z) + 5 = 0 + i z + i = z i z z z 970 0 y zz + i z z) + 5 = 0 z i) z + i) = 9 5 = 4 z i = i) zz i z z) + = a {zz + i z z) + 4} a ) zz + a + ) z z) + 4a = 0 4a a = 5 a = x i) i) : c Darumafactory

More information

日本化学療法学会雑誌第66巻第2号

日本化学療法学会雑誌第66巻第2号 173 Table 1.Detection rates of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, Haemophilus influenzae and adenovirus from male urethritis in Urethritis No.

More information

Microsoft PowerPoint - protein1.ppt [互換モード]

Microsoft PowerPoint - protein1.ppt [互換モード] 生物物理化学 1 セントラルドグマ (central doguma) DA から蛋白質が作られるまでの道筋 フランシス クリックが提唱した 原核生物と真核生物では 若干関与するタンパク質が異なるが 基本的には同じメカニズムで転写 翻訳 タンパク合成が行われる 原核生物 : 核膜が無い ( 構造的に区別出来る核を持たない ) 細胞 ( これを原核細胞という ) から成る生物で 細菌類や藍藻類がこれに属する

More information

光合成におけるエネルギー生産について

光合成におけるエネルギー生産について CO 2 CO 2 RuBisCO phytochromobilin Pr Pfr CO 2 1 CO2 a b b CHO a a - H+ H+ e - e - Mn Yz e - Q B P680 Q A Mn Yz P680 Q A Q B e ē - e - Mn Yz P680 Q A Q B Mn e - Yz P680 e - Q A Q B H 2 O Mn Yz e - P680

More information

Application Note

Application Note LAAN-D-MS007 GC/MS を用いた緑茶葉中代謝物の プロファイリング GC/MS Application Note No. 4 GC/MS Metabolomics & Life Science Project (Yuki Sakamoto, Katsuhiro Nakagawa, Haruhiko Miyagawa, Shuichi Kawana, Shinji Fukumoto) Tairo

More information

,328 C 6426 H 9900 N 1700 O 2008 S , ,

,328 C 6426 H 9900 N 1700 O 2008 S , , 2458 13 4 24 1 11 9 17 1,328 C 6426 H 9900 N 1700 O 2008 S 44 145,000 148,000 10 11 27 2 13 4 24 11 9 17 (1) CD20 B CD20 (2) infusion reaction infusion-associated symptom CD20 B 1 375mg/m 2 1 4 3 Heavy

More information

メタボロミクス代謝産物分析編_v19.indd

メタボロミクス代謝産物分析編_v19.indd 2 3 μ μ μ μ μ μ μ 4 18. C18:1, n-9 17. C18:1, n-7 16. C16:0 12. C18:2, n-6 15. C20:3, n-6 14. C22:5, n-6 22. C18:0 24. C19:0 23. C20:1, n-9 21. C17:0 20. C20:2, n-6 19. C22:4, n-6 29. C24:0 28. C24:1,

More information

日本化学療法学会雑誌第57巻第1号

日本化学療法学会雑誌第57巻第1号 In vitro Streptococcus pneumoniae Escherichia coli in vitro Streptococcus pneumoniae Escherichia coli µs. pneumoniae E. coli µ Key words in vitrostreptococcus pneumoniae Escherichia coli Escherichia coli

More information

h1_4.ai

h1_4.ai For the Customer, and for Society. It s our Commitment. SynergiFusion-RP C8 C8 C8 C8 C5 C93.Phenylpropanolamine 3.Pseudoephedrine 3 : Synergi 4µ Fusion-RP : 5 x 4.6mm : mm Potassium Phosphate, p.5 / Methanol

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

13 0 1 1 4 11 4 12 5 13 6 2 10 21 10 22 14 3 20 31 20 32 25 33 28 4 31 41 32 42 34 43 38 5 41 51 41 52 43 53 54 6 57 61 57 62 60 70 0 Gauss a, b, c x, y f(x, y) = ax 2 + bxy + cy 2 = x y a b/2 b/2 c x

More information

遺伝子発現データの クラスタリングの理論的背景

遺伝子発現データの クラスタリングの理論的背景 自己組織化マップ Self-Organization Map (SOM) 自己組織化マップとは? K 平均アルゴリズムは あらかじめクラスター数 K を設定し 互いに近い値を持った各要素が同一クラスターに所属するように所属クラスターを決めてゆく 自己組織化マップは互いに近い値を持った各要素が近くなるように低い次元上にマップする 自己組織化マップは 1988 年に Kohonen が提案した (Kohonen

More information

Activation and Control of Electron-Transfer Reactions by Noncovalent Bond

Activation and Control of Electron-Transfer Reactions by Noncovalent Bond 2 + 4e- + 4 + hν 2 2 1 2 20 J. Am. Chem. oc. Angew. Chem. Int. Ed. umber of Papers 15 10 5 0 1998 1999 2000 2001 2002 2003 Year : J. Am. Chem. oc. (Trost, B. M.; tanford University, UA) 3 π 1/2 k ET =

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

USP 最新通知事項 2018年4月

USP 最新通知事項 2018年4月 USP 通知事項 2018 年 4 1 新しい標準品の情報です Catalog # Description 容量ロット 1098570 Celecoxib Related Compound D 25 mg F083E0 1133558 Choline Fenofibrate 50 mg F088G0 1175784 Desvenlafaxine Related Compound A 25 mg F076C0

More information

5. 5.1,, V, ,, ( 5.1), 5.2.2,,,,,,,,,, 5.2.3, 5.2 L1, L2, L3 3-1, 2-2, 1-3,,, L1, L3, L2, ,,, ( 5.3),,, N 3 L 2 S L 1 L 3 5.1: 5.2: 1

5. 5.1,, V, ,, ( 5.1), 5.2.2,,,,,,,,,, 5.2.3, 5.2 L1, L2, L3 3-1, 2-2, 1-3,,, L1, L3, L2, ,,, ( 5.3),,, N 3 L 2 S L 1 L 3 5.1: 5.2: 1 5. 5.1,,, 5.2 5.2.1,, ( 5.1), 5.2.2,,,,,,,,,, 5.2.3, 5.2 L1, L2, L3 31, 22, 13,,, L1, L3, L2, 0 5.2.4,,, ( 5.3),,, N 3 L 2 S L 1 L 3 5.1: 5.2: 1 D C 1 0 0 A C 2 2 0 j X E 0 5.3: 5.5: f,, (),,,,, 1, 5.2.6

More information

Microsoft Word - 化学構造式集 doc

Microsoft Word - 化学構造式集 doc 抗生物質 (Antibiotics.) (1) 複素環式のもの (eterocyclic) - ノボビオシン (ovobiocin) - セファロスポリン類 (ephalosporins) セファロスポリン核を有するもの :R1 R2 が変わる (Those which have cephalosporin nucleus: R1 and R2 to change.) R 1 R 2 -- セファロスポリン

More information

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m 1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N

More information

目次 基礎 : 実験を始める前に 3 細胞培養 3 培養細胞 3 無菌操作と滅菌 3 基本培地 3 血清 3 無血清培地 3 培養 4 細胞培養の方法 4 実験プロトコール 4 関連情報 ( フィーダー細胞 マイトマイシン C 溶液 Y Human FGF-basic StemBeads

目次 基礎 : 実験を始める前に 3 細胞培養 3 培養細胞 3 無菌操作と滅菌 3 基本培地 3 血清 3 無血清培地 3 培養 4 細胞培養の方法 4 実験プロトコール 4 関連情報 ( フィーダー細胞 マイトマイシン C 溶液 Y Human FGF-basic StemBeads 目次 基礎 : 実験を始める前に 3 細胞培養 3 培養細胞 3 無菌操作と滅菌 3 基本培地 3 血清 3 無血清培地 3 培養 4 細胞培養の方法 4 実験プロトコール 4 関連情報 ( フィーダー細胞 マイトマイシン C 溶液 Y-27632 Human FGF-basic StemBeads FGF2 StemBeads シリーズ Leukemia Inhibitory Factor(LIF))

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 2016 年 10 月 19 日 ( 水 ) バイオ情報解析演習 ウェブツールを活用した生物情報解析 (1) 配列と代謝経路の解析の基礎 有用物質生産菌を合理的に作ろう! 設計 試作 ベンチテスト 完成 プラスミド 効率的な代謝経路を設計する 文献調査代謝パスウェイの探索代謝シミュレーション 実際に微生物に組み込む データベースから有用遺伝子を探索する遺伝子組換え技術 培養をして問題点を突き止める

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション アミノ酸代謝 (1) 平成 30 年度 6 月 14 日 1 限病態生化学分野 吉澤達也 アミノ酸代謝 アミノ酸の修飾 食物タンパク質 消化吸収 分解 タンパク質 (20 種類 +α) 遊離アミノ酸 生合成 アミノ酸の生合成 ( 栄養学的非必須アミノ酸 ) 窒素 分解 炭素骨格 非タンパク質性誘導体 ( 神経伝達物質 ホルモン アミノ糖など ) 尿素サイクル 代謝中間体 尿素 糖質 脂質 エネルギー

More information

Microsoft PowerPoint 熊大 城野.ppt

Microsoft PowerPoint 熊大 城野.ppt 平成 20 年度新技術説明会 アミロイド線維形成阻害剤を用いた アミロイドーシスの治療 熊本大学大学院医学薬学研究部 病態情報解析学分野 講師 城野博史 研究背景 アミロイドーシス 生体内にアミロイド ( ナイロン様の重合物質 ) が沈着し臓器障害を引き起こす病気 ーナイロンの配列に似ているー アミロイドーシスの分類 [ 全身性アミロイドーシス ] 免疫グロブリン性アミロイドーシス 1) AL アミロイドーシス

More information